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Letter to the Editor
Future prospects for the utility of interferon assays in tuberculosis diagnosis
Madam, tuberculosis remains an important global
health problem. For Pakistan, the control of the disease
should be a top priority as Pakistan is the 7th leading
country with tuberculous disease.1 Tuberculosis remains a
diagnostic dilemma for physicians in endemic areas. Its
ability to involve virtually any organ of the body along
with its high prevalence in the region warrants its
assignment to the list of differential diagnoses for a
multitude of presentations. The pursuit of a definitive
diagnosis for tuberculosis is imperative because of the
consideration of side effects of anti-tuberculous therapy in
the recipient. On the other hand, it is important to treat this
condition because of its potential for curability; failure to
treat can have devastating effects on individuals with this
disease. Moreover, it is important to correctly recognize
individuals with the disease from amongst the pool of
infected individuals; especially where prior BCG
vaccination can confound the results of commonly
employed diagnostic assays. 
The traditional tuberculin skin test has remained a
widely employed tool for diagnosing tuberculosis with
various "risk-stratified" cut-offs being followed in various
regions of the world for different sub-groups of the
population.2 However, the tuberculin skin test is fraught
with shortcomings such as high dependency on the reader
and the need for patients to return to get the test read after
an appropriate time period;2 both of these factors are
important considerations in developing countries. 
Interferon gamma assay is an alternative assay that is
now rapidly emerging as a modern diagnostic tool for
tuberculosis.2 For any screening test, sensitivity is one of
the most important parameters. Many studies have reported
that the sensitivity and specificity of interferon assays is
higher as compared to tuberculin skin test as far as latent
tuberculosis is concerned.2-4 Limited data has also shown an
association between interferon gamma response and
progression of latent tuberculosis to active tuberculosis.3
Mycobacterial antigen six kDa early secreted antigenic
target (ESAT6) and culture filtrate protein 10 (CFP10) can
be used to detect M. tuberculosis associated interferon
gamma responses. In a study conducted in Pakistan recently,
it was seen that ESAT6-induced interferon gamma and
CXCL9 responses discriminated the severity of tuberculous
infections.5
However, the cost of this assay and the juxtaposed
need for appropriate laboratory facilities and personnel are
factors that ostensibly preclude its wider utility in
developing countries.2 Based on available literature,
interferon gamma assays may not be conclusively
recommended as a replacement for tuberculin skin testing
because of lack of studies in endemic areas. Future studies
done in endemic countries will, therefore, be instrumental in
delineating the superiority of interferon gamma assays over
the tuberculin skin test.
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